Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

M. Groevdal; R. Kahn; M. Jansson; A. Aggerholm; P. Antunovic; Jan Astermark; P. Bernell; L. Engstroem; L. Kjeldsen; O. Linder; L. Nilsson; A. Olsson; M. Skovholm; J. Tangen

doi:10.1016/S0145-2126(09)70069-4

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

M. Groevdal, R. Kahn, M. Jansson, A. Aggerholm, P. Antunovic, Jan Astermark, P. Bernell, L. Engstroem, L. Kjeldsen, O. Linder, L. Nilsson, A. Olsson, M. Skovholm, J. Tangen

Clinical Coagulation, Malmö

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Pages (from-to)	S49-S50
Journal	Leukemia Research
Volume	33
Issue number	Suppl 1
DOIs	https://doi.org/10.1016/S0145-2126(09)70069-4
Publication status	Published - 2009
Event	10th International Symposium on Myelodysplastic Syndromes - Patras, Greece Duration: 2009 May 6 → 2009 May 9

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0145-2126(09)70069-4

Cite this

Groevdal, M., Kahn, R., Jansson, M., Aggerholm, A., Antunovic, P., Astermark, J., Bernell, P., Engstroem, L., Kjeldsen, L., Linder, O., Nilsson, L., Olsson, A., Skovholm, M., & Tangen, J. (2009). Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy. Leukemia Research, 33(Suppl 1), S49-S50. https://doi.org/10.1016/S0145-2126(09)70069-4

@article{84ef21537faf4fbaa4b8d6514420c27c,

title = "Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy",

author = "M. Groevdal and R. Kahn and M. Jansson and A. Aggerholm and P. Antunovic and Jan Astermark and P. Bernell and L. Engstroem and L. Kjeldsen and O. Linder and L. Nilsson and A. Olsson and M. Skovholm and J. Tangen",

year = "2009",

doi = "10.1016/S0145-2126(09)70069-4",

language = "English",

volume = "33",

pages = "S49--S50",

journal = "Leukemia Research",

issn = "1873-5835",

publisher = "Elsevier",

number = "Suppl 1",

note = "10th International Symposium on Myelodysplastic Syndromes ; Conference date: 06-05-2009 Through 09-05-2009",

}

Groevdal, M, Kahn, R, Jansson, M, Aggerholm, A, Antunovic, P, Astermark, J, Bernell, P, Engstroem, L, Kjeldsen, L, Linder, O, Nilsson, L, Olsson, A, Skovholm, M & Tangen, J 2009, 'Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy', Leukemia Research, vol. 33, no. Suppl 1, pp. S49-S50. https://doi.org/10.1016/S0145-2126(09)70069-4

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy. / Groevdal, M.; Kahn, R.; Jansson, M. et al.
In: Leukemia Research, Vol. 33, No. Suppl 1, 2009, p. S49-S50.

Research output: Contribution to journal › Published meeting abstract › peer-review

TY - JOUR

T1 - Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy

AU - Groevdal, M.

AU - Kahn, R.

AU - Jansson, M.

AU - Aggerholm, A.

AU - Antunovic, P.

AU - Astermark, Jan

AU - Bernell, P.

AU - Engstroem, L.

AU - Kjeldsen, L.

AU - Linder, O.

AU - Nilsson, L.

AU - Olsson, A.

AU - Skovholm, M.

AU - Tangen, J.

PY - 2009

Y1 - 2009

U2 - 10.1016/S0145-2126(09)70069-4

DO - 10.1016/S0145-2126(09)70069-4

M3 - Published meeting abstract

SN - 1873-5835

VL - 33

SP - S49-S50

JO - Leukemia Research

JF - Leukemia Research

IS - Suppl 1

T2 - 10th International Symposium on Myelodysplastic Syndromes

Y2 - 6 May 2009 through 9 May 2009

ER -